Works matching DE "INTRANASAL medication"

Results: 2592

Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study.

Published in:

Clinical & Experimental Allergy, 2025, v. 55, n. 3, p. 226, doi. 10.1111/cea.70004

By:

Sousa‐Pinto, Bernardo;
Costa, Elísio M.;
Vieira, Rafael José;
Klimek, Ludger;
Czarlewski, Wienczyslawa;
Pfaar, Oliver;
Bedbrook, Anna;
Amaral, Rita;
Brussino, Luisa;
Kvedariene, Violeta;
Larenas‐Linnemann, Desiree E.;
Iinuma, Tomohisa;
Pham‐Thi, Nhân;
Regateiro, Frederico S.;
Taborda‐Barata, Luis;
Ventura, Maria Teresa;
Ansotegui, Ignacio J.;
Bergmann, Karl C.;
Canonica, G. Walter;
Cardona, Victoria

Publication type:

Article

THE REASON FOR THE SNEEZING: ORAL PHENYLEPHRINE AND THE FDA'S FOCUS ON SAFETY AT THE EXPENSE OF EFFECTIVENESS.

Published in:

Alabama Law Review, 2025, v. 76, n. 3, p. 623

By:

Hall, Daniel

Publication type:

Article

Adelmidrol to fight upper airways inflammation in children: a pilot case control study to safety and efficacy.

Published in:

European Archives of Oto-Rhino-Laryngology, 2025, v. 282, n. 6, p. 3075, doi. 10.1007/s00405-025-09375-z

By:

Della Volpe, Antonio;
Bruno, Chiara;
De Luca, Pietro;
Ralli, Massimo;
Di Stadio, Arianna

Publication type:

Article

A comment on oral phenylephrine use in sinonasal pathologies.

Published in:

European Archives of Oto-Rhino-Laryngology, 2025, v. 282, n. 6, p. 3381, doi. 10.1007/s00405-025-09348-2

By:

Hussain, Syed Ahmed Shahzaeem;
Talha, Muhammad;
Tariq, Muhammad Faizan

Publication type:

Article

Atherosclerosis enhances the efficacy of liposome-encapsulated bromocriptine in reducing the incidence of prolactinemia in pituitary tumors.

Published in:

Journal of Nanobiotechnology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12951-025-03465-0

By:

Zhang, Zhe;
Jia, Guangyu;
Wang, Qi;
Yu, Yamei;
Tang, Xiaolong;
Zheng, Heqing;
Yang, Xinyu;
Xiao, Yao;
Ou, Yangrui;
Jiang, Jingjing;
Guo, Hua;
Wang, Ye;
Li, Shiyong

Publication type:

Article

Effective Management of Breakthrough Pain in Cancer Patients Using Intranasal Fentanyl.

Published in:: Oncology (08909091), 2008, v. 22, n. 8, p. 956
Publication type:: Article

Comment on FDA's Breakthrough Therapy Designation of Intranasal Esketamine for the Treatment of Major Depressive Disorder with Imminent Risk of Suicide.

Published in:

Klinik Psikofarmakoloji Bulteni, 2016, v. 26, n. 4, p. 329, doi. 10.5455/bcp.20161027122045

By:

Thomas, Reji;
Cetin, Mesut;
Baker, Glen B.;
Dursun, Serdar M.

Publication type:

Article

Nasal Testosterone in Testosterone Deficiency: Is It a Paradigm Shift Yet?

Published in:

2021

By:

Karthikeyan, Vilvapathy Senguttuvan

Publication type:

Letter

Acute Treatment of Migraine: What has Changed in Pharmacotherapies?

Published in:

2021

By:

Chun‑Pai Yang;
Kuo‑Ting Huang;
Ching‑Mao Chang;
Cheng‑Chia Yang;
Shuu‑Jiun Wang;
Yang, Chun-Pai;
Huang, Kuo-Ting;
Chang, Ching-Mao;
Yang, Cheng-Chia;
Wang, Shuu-Jiun

Publication type:

journal article

High-dose-rate brachytherapy for intranasal tumours in dogs: results of a pilot study.

Published in:

Veterinary & Comparative Oncology, 2006, v. 4, n. 4, p. 218, doi. 10.1111/j.1476-5829.2006.00109.x

By:

Klueter, S.;
Krastel, D.;
Ludewig, E.;
Reischauer, A.;
Heinicke, F.;
Pohlmann, S.;
Wolf, U.;
Grevel, V.;
Hildebrandt, G.

Publication type:

Article

Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal women.

Published in:

Osteoporosis International, 2015, v. 26, n. 1, p. 383, doi. 10.1007/s00198-014-2937-5

By:

Rizzoli, R.;
Sigaud, A.;
Azria, M.;
Herrmann, F.

Publication type:

Article

A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine.

Published in:

Journal of Headache & Pain, 2017, v. 18, n. 1, p. 1, doi. 10.1186/s10194-017-0740-3

By:

Munjal, Sagar;
Brand-Schieber, Elimor;
Allenby, Kent;
Spierings, Egilius;
Cady, Roger;
Rapoport, Alan

Publication type:

Article

A comparative assessment of the clinical efficacy of intranasal desmopressin spray and diclofenac in the treatment of renal colic.

Published in:

Urological Research, 2011, v. 39, n. 5, p. 397, doi. 10.1007/s00240-010-0354-6

By:

Kumar, Santosh;
Behera, Nimai;
Sarkar, Debansu;
Prasad, Seema;
Mandal, Arup;
Singh, S.

Publication type:

Article

The anatomical and clinical details of the pterygoid canal: a three-dimensional reconstructive virtual anatomic evaluation based on CT.

Published in:

Surgical & Radiologic Anatomy, 2014, v. 36, n. 2, p. 181, doi. 10.1007/s00276-013-1161-x

By:

Fu, Zhenghao;
Chen, Yizhao;
Jiang, Weiping;
Yang, Shuo;
Zhang, Jing;
Zhang, Wangming;
Zhang, Shizhong;
Ke, Yiquan

Publication type:

Article

Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice.

Published in:

Experimental Brain Research, 2012, v. 219, n. 3, p. 381, doi. 10.1007/s00221-012-3101-0

By:

Fine, J.;
Baillargeon, A.;
Renner, D.;
Hoerster, N.;
Tokarev, J.;
Colton, S.;
Pelleg, A.;
Andrews, A.;
Sparley, K.;
Krogh, K.;
Frey, W.;
Hanson, L.

Publication type:

Article

Attention and contrast differently affect contextual integration in an orientation discrimination task.

Published in:

Experimental Brain Research, 2008, v. 187, n. 4, p. 535, doi. 10.1007/s00221-008-1322-z

By:

Roberts, M.;
Thiele, A.

Publication type:

Article

Induction of muscle cramps by nociceptive stimulation of latent myofascial trigger points.

Published in:

Experimental Brain Research, 2008, v. 187, n. 4, p. 623, doi. 10.1007/s00221-008-1331-y

By:

Hong-You Ge;
Yang Zhang;
Boudreau, Shellie;
Shou-Wei Yue;
Arendt-Nielsen, Lars

Publication type:

Article

The pharmacokinetic interaction between nasally administered naloxone and the opioid remifentanil in human volunteers.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 12, p. 1901, doi. 10.1007/s00228-021-03190-1

By:

Tylleskar, Ida;
Skarra, Sissel;
Skulberg, Arne Kristian;
Dale, Ola

Publication type:

Article

Pharmacokinetics and pharmacodynamics of intranasal remimazolam—a randomized controlled clinical trial.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 11, p. 1505, doi. 10.1007/s00228-020-02984-z

By:

Pesic, Marija;
Schippers, Frank;
Saunders, Rob;
Webster, Lyn;
Donsbach, Martin;
Stoehr, Thomas

Publication type:

Article

Pharmacokinetics and -dynamics of intramuscular and intranasal naloxone: an explorative study in healthy volunteers.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 7, p. 873, doi. 10.1007/s00228-018-2443-3

By:

Skulberg, Arne Kristian;
Tylleskar, Ida;
Nilsen, Turid;
Skarra, Sissel;
Salvesen, Øyvind;
Sand, Trond;
Loftsson, Thorsteinn;
Dale, Ola

Publication type:

Article

Pharmacokinetics of a new, nasal formulation of naloxone.

Published in:

European Journal of Clinical Pharmacology, 2017, v. 73, n. 5, p. 555, doi. 10.1007/s00228-016-2191-1

By:

Tylleskar, Ida;
Skulberg, Arne;
Nilsen, Turid;
Skarra, Sissel;
Jansook, Phatsawee;
Dale, Ola

Publication type:

Article

Buccal and intranasal lorazepam clinical pharmacokinetics: can it adequately compete with intravenous lorazepam in pediatric care patients?

Published in:

2012

By:

Srinivas, Nuggehally

Publication type:

Letter

Pharmacokinetics of buccal and intranasal lorazepam in healthy adult volunteers.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 2, p. 155, doi. 10.1007/s00228-011-1109-1

By:

Anderson, Mark;
Tambe, Parag;
Sammons, Helen;
Mulla, Hussain;
Cole, Richard;
Choonara, Imti

Publication type:

Article

Bioavailability of dexmedetomidine after intranasal administration.

Published in:

European Journal of Clinical Pharmacology, 2011, v. 67, n. 8, p. 825, doi. 10.1007/s00228-011-1002-y

By:

Iirola, Timo;
Vilo, Sanna;
Manner, Tuula;
Aantaa, Riku;
Lahtinen, Maria;
Scheinin, Mika;
Olkkola, Klaus

Publication type:

Article

Nasal Polyposis and Its Association with Cardiac Functions.

Published in:

2021

By:

Dhiman, Sapna;
Dhiman, Abhishek;
Azad, Ramesh K.;
Negi, Prakash C.;
Lal, Bhushan;
Thakur, Jagdeep S.

Publication type:

journal article

Epinephrine Nasal Spray Shows Rapid Symptom Relief in Children: Daily Dose.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Jennings, Sydney

Publication type:

Article

FDA Approves Neffy 1 mg Epinephrine Nasal Spray: Daily Dose.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Jennings, Sydney

Publication type:

Article

FDA Approves Neffy 1 mg Epinephrine Nasal Spray, Only Needle-Free Treatment for Patients Weighing Less Than 30 kg.

Published in:: Patient Care (Online), 2025, p. N.PAG
Publication type:: Article

Epinephrine Nasal Spray Shows Rapid Symptom Relief in Pediatric Anaphylaxis Study.

Published in:

2025

By:

Halsey, Grace

Publication type:

Abstract

New neffy (epinephrine nasal spray) Data To Be Shared in 9 Presentations at 2025 AAAAI.

Published in:: Patient Care (Online), 2025, p. N.PAG
Publication type:: Article

PatientCare Launch Lens: A look at NEFFY® (epinephrine nasal spray).

Published in:: Patient Care (Online), 2025, p. 4
Publication type:: Article

FDA Approves First Monotherapy Standalone MDD Treatment: Daily Dose.

Published in:

Patient Care (Online), 2025, p. 2

By:

Jennings, Sydney

Publication type:

Article

FDA Approves Esketamine as Monotherapy for Adults With Treatment-Resistant Depression.

Published in:: Patient Care (Online), 2025, p. 3
Publication type:: Article

Neffy Update: FDA to Review 1 mg Version in First Quarter 2025, for Young Children with Type 1 Allergic Reactions.

Published in:: Patient Care (Online), 2025, p. 1
Publication type:: Article

Orexo Announces Positive Topline Data for Nasal Epinephrine Powder OX640 in People with Allergic Rhinitis.

Published in:

Patient Care (Online), 2025, p. 3

By:

Jennings, Sydney

Publication type:

Article

FDA May End Use of Oral Phenylephrine as Nasal Decongestant Ingredient in OTC Products: A decision on ending use of oral phenylephrine as a nasal decongestant in OTC products will be made following public comment on FDA's proposed order.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Novel DHE Nasal Spray for Acute Treatment of Migraine: Daily Dose.

Published in:

2024

By:

Jennings, Sydney

Publication type:

Abstract

New Data on Needle Free Epinephrine Spray Presented at ACAAI 2024.

Published in:: Patient Care (Online), 2024, p. 1
Publication type:: Article

Novel DHE Nasal Spray Safe, Effective For Acute Treatment of Migraine in Long-Term Safety Trial.

Published in:

Patient Care (Online), 2024, p. 5

By:

Halsey, Grace

Publication type:

Article

First Self-Administered Flu Vaccine Approved by US FDA.

Published in:

Patient Care (Online), 2024, p. 2

By:

Jennings, Sydney

Publication type:

Article

FDA Approves Neffy as First Nasal Spray for Allergic Reactions: Daily Dose.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

Neffy, First Needle-Free Epinephrine, Fills a Deep Need for Patients, says Allergy Expert.

Published in:

Patient Care (Online), 2024, p. 11

By:

Halsey, Grace

Publication type:

Article

Neffy May be Safe, Effective for Treatment of Urticaria Flares: Daily Dose.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

Neffy May be Safe, Effective for Treatment of Urticaria Flares: Daily Dose.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

Phase 3 Findings on Neffy for Pediatric Patients with Severe Allergies: A Conversation with Motohiro Ebisawa, MD, PhD.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

New neffy Data on Clinical Efficacy Presented at 2024 AAAAI Annual Meeting.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Shelf-Life Extended for Narcan Nasal Spray, FDA Announces.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Efficacy of Intranasal Midazolam in Cessation of Hypercyanotic Spells in Children with Tetralogy of Fallot.

Published in:

Caspian Journal of Pediatrics, 2023, v. 9, p. 1, doi. 10.22088/CJP.BUMS.9.1.16

By:

Riahi, Kurosh;
Najibi, Babak;
Razmara, Mehrdad

Publication type:

Article

Assessing serum cytokine and immunoglobulin levels in patients with allergic rhinitis and allergic rhinoconjunctivitis before and after treatment supplemented with macromycetes.

Published in:

Journal of Ophthalmology (Ukraine) / Oftalʹmologičeskij Žurnal, 2023, n. 5, p. 22, doi. 10.31288/oftalmolzh202352226

By:

Bogdanov, V. K.;
Pukhlyk, S. M.;
Makarova, M. B.;
Poliakova, S. I.;
Bogdanov, K. G.

Publication type:

Article

Allergic rhinitis: review of the diagnosis and management: South African Allergic Rhinitis Working Group.

Published in:

SA Pharmaceutical Journal Incorporating Pharmacy Management, 2023, v. 90, n. 6, p. 14

By:

Richards, G. A.;
McDonald, M.;
Gray, C. L.;
de Waal, P.;
Friedman, R.;
Hockman, M.;
Karabus, S. J.;
Lodder, C. M.;
Mabelane, T.;
Mosito, S. M.;
Nanan, A.;
Peter, J. G.;
Quitter, T. H. C.;
Seedat, R.;
van den Berg, S.;
van Niekerk, A.;
Vardas, E.;
Feldman, C.

Publication type:

Article